m 6 A RNA methyltransferases METTL3/14 regulate immune responses to anti‐PD‐1 therapy
出版年份 2020 全文链接
标题
m
6
A RNA methyltransferases METTL3/14 regulate immune responses to anti‐PD‐1 therapy
作者
关键词
-
出版物
EMBO JOURNAL
Volume 39, Issue 20, Pages -
出版商
EMBO
发表日期
2020-09-23
DOI
10.15252/embj.2020104514
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment
- (2020) Na Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Immunotherapy in colorectal cancer: rationale, challenges and potential
- (2019) Karuna Ganesh et al. Nature Reviews Gastroenterology & Hepatology
- Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
- (2019) Dali Han et al. NATURE
- Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response
- (2019) Rajarsi Mandal et al. SCIENCE
- Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation
- (2019) Huamin Wang et al. Nature Communications
- Regulation of Gene Expression by N-methyladenosine in Cancer
- (2019) Jun Liu et al. TRENDS IN CELL BIOLOGY
- m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade
- (2019) Seungwon Yang et al. Nature Communications
- Association of N6-methyladenosine with viruses and related diseases
- (2019) Fang Wu et al. Virology Journal
- Atlas of quantitative single-base-resolution N6-methyl-adenine methylomes
- (2019) Casslynn W. Q. Koh et al. Nature Communications
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- RNA N6-methyladenosine modification in cancers: current status and perspectives
- (2018) Xiaolan Deng et al. CELL RESEARCH
- METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m 6 A Modification
- (2018) Hengyou Weng et al. Cell Stem Cell
- RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2
- (2018) Mengnuo Chen et al. HEPATOLOGY
- IRF1 supports DNA binding of STAT1 by promoting its phosphorylation
- (2018) Kosuke Zenke et al. IMMUNOLOGY AND CELL BIOLOGY
- The m6A Reader ECT2 Controls Trichome Morphology by Affecting mRNA Stability in Arabidopsis
- (2018) Lian-Huan Wei et al. PLANT CELL
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- Chemical Modifications in the Life of an mRNA Transcript
- (2018) Sigrid Nachtergaele et al. Annual Review of Genetics
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)
- (2018) Marcin Kowanetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cross-talk among writers, readers, and erasers of m6A regulates cancer growth and progression
- (2018) Subbarayalu Panneerdoss et al. Science Advances
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
- (2017) Isaia Barbieri et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
- (2017) Ly P Vu et al. NATURE MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- m 6 A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
- (2017) Qi Cui et al. Cell Reports
- Emerging links between m6A and misregulated mRNA methylation in cancer
- (2017) Samie R. Jaffrey et al. Genome Medicine
- Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation
- (2017) Rūta Veinalde et al. OncoImmunology
- Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
- (2016) Vishwajith Sridharan et al. BRITISH JOURNAL OF CANCER
- Dynamics of Human and Viral RNA Methylation during Zika Virus Infection
- (2016) Gianluigi Lichinchi et al. Cell Host & Microbe
- METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulatingN6-methyladenosine-dependent primary MicroRNA processing
- (2016) Jin-zhao Ma et al. HEPATOLOGY
- Nuclear m 6 A Reader YTHDC1 Regulates mRNA Splicing
- (2016) Wen Xiao et al. MOLECULAR CELL
- The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells
- (2016) Gianluigi Lichinchi et al. Nature Microbiology
- N6-methyladenosine Modulates Messenger RNA Translation Efficiency
- (2015) Xiao Wang et al. CELL
- RNAN6-methyladenosine methylation in post-transcriptional gene expression regulation
- (2015) Yanan Yue et al. GENES & DEVELOPMENT
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase
- (2014) Xiao-Li Ping et al. CELL RESEARCH
- Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers
- (2014) Yuan Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- N6-methyladenosine-dependent regulation of messenger RNA stability
- (2013) Xiao Wang et al. NATURE
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
- (2013) Jianzhao Liu et al. Nature Chemical Biology
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
- (2012) Kate D. Meyer et al. CELL
- ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
- (2012) Guanqun Zheng et al. MOLECULAR CELL
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
- (2012) Dan Dominissini et al. NATURE
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
- (2011) Guifang Jia et al. Nature Chemical Biology
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Regulation of the expression of inducible nitric oxide synthase
- (2010) Andrea Pautz et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started